Prévisions du marché de la nutrition parentérale en Asie-Pacifique jusqu’en 2030 – Analyse régionale – par type de nutriment (solution d’acides aminés à dose unique, émulsion lipidique parentérale, glucides, oligo-éléments et vitamines et minéraux) et utilisateur final (hôpitaux, cliniques et autres)

BMIRE00030378 | Pages: 95 | Pharmaceuticals | Jul 2024 | Type: Regional | Status: Published
Le marché de la nutrition parentérale en Asie-Pacifique était évalué à 861,59 millions de dollars US en 2022 et devrait atteindre 1 471,33 millions de dollars US d’ici 2030 ; on estime qu\'il enregistrera un TCAC de 6,9 % de 2022 à 2030.

Les développements de nouveaux produits par les entreprises stimulent le marché de la nutrition parentérale en Asie-Pacifique

Les entreprises opérant sur le marché de la nutrition médicale parentérale se concentrent constamment sur de nouveaux lancements de produits, qui les aident à améliorer leurs ventes. Quelques-uns des développements notables sur le marché de la nutrition parentérale sont mentionnés ci-dessous :

En 2023, Baxter Corée a lancé Olimel N12E, un fluide de nutrition parentérale totale (TPN) riche en protéines pour les patients gravement malades.

En 2023, JW Holdings a commencé à exporter à grande échelle Winuf Central 736/1 085 ml, une nutrition parentérale totale (TPN) à trois chambres, vers la Mongolie via AsiaPharma LLC, une société pharmaceutique locale.

Ainsi, le développement de nouveaux produits de nutrition devrait créer des opportunités de croissance du marché au cours de la période de prévision.

Aperçu du marché de la nutrition parentérale en Asie-Pacifique

La Chine est confrontée à un lourd fardeau de cancer de l\'estomac en raison de la prévalence croissante de l\'infection à H. pylori parmi la population. Une étude (2021) réalisée par le Centre international de recherche sur le cancer (CIRC) de l\'Organisation mondiale de la santé et des institutions partenaires au Royaume-Uni et en Chine a révélé que l\'infection à H. pylori est répandue en Chine. En outre, l’infection à H. pylori était la principale cause de 62,1 % des cas de cancer gastrique cardia et de 78,5 % des cas de cancer gastrique non cardiaque chez les adultes de plus de 30 ans. Cette étude du CIRC estime qu\'environ 340 000 cas de cancer gastrique dus à une infection à H. pylori surviennent chaque année en Chine. Selon l\'étude Global Burden of Diseases publiée en octobre 2020, le cancer de l\'estomac figurait parmi les 10 principales causes de décès en 2019. De même, selon les dernières données du Centre international de recherche sur le cancer (CIRC), l\'incidence estimée standardisée selon l\'âge Le taux de cancer de l\'estomac en Chine est de 20,58 pour 100 000 et le taux brut est de 33,06. Selon la même source, le nombre estimé de nouveaux cas (âgés de 0 à 74 ans) en 2020 pour les deux sexes était de 478 508. Ainsi, en raison des facteurs mentionnés ci-dessus, le marché de la nutrition parentérale connaîtra probablement une croissance remarquable en Chine au cours de la période de prévision.

Revenus et prévisions du marché de la nutrition parentérale en Asie-Pacifique jusqu\'en 2030 (millions de dollars américains)

Segmentation du marché de la nutrition parentérale en Asie-Pacifique

Le marché de la nutrition parentérale en Asie-Pacifique est segmenté en fonction des nutriments type, utilisateur final et pays. En fonction du type de nutriments, le marché de la nutrition parentérale en Asie-Pacifique est classé en solution à dose unique d’acides aminés, émulsion lipidique parentérale, glucides, oligo-éléments, vitamines et minéraux. Le segment des solutions d\'acides aminés à dose unique détenait la plus grande part de marché en 2022.

Par utilisateur final, le marché de la nutrition parentérale en Asie-Pacifique est segmenté en hôpitaux, cliniques et autres. Le segment des hôpitaux détenait la plus grande part de marché en 2022.

En fonction des pays, le marché de la nutrition parentérale en Asie-Pacifique est segmenté en Chine, au Japon, en Inde, en Australie, en Corée du Sud et dans le reste de l\'Asie-Pacifique. La Chine a dominé la part de marché de la nutrition parentérale en Asie-Pacifique en 2022.

ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd et Vifor Pharma Management AG comptent parmi les principaux acteurs opérant sur le marché de la nutrition parentérale en Asie-Pacifique.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Parenteral Nutrition Market - Key Industry Dynamics

4.1 Market Drivers

4.1.1 Rise in Prevalence of Gastrointestinal Diseases

4.1.2 Surge in Cases of Malnutrition and Premature Births

4.2 Market Restraints

4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems

4.3 Market Opportunities

4.3.1 New Product Developments by Companies

4.4 Future Trends

4.4.1 Innovation in Formulations of Nutrition Products

4.5 Impact Analysis

5. Parenteral Nutrition Market - Asia Pacific Market Analysis

5.1 Overview

5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030

6. Asia Pacific Parenteral Nutrition Market Analysis - by Nutrient Type

6.1 Overview

6.2 Single Dose Amino Acid Solution

6.2.1 Overview

6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

6.3 Parenteral Lipid Emulsion

6.3.1 Overview

6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Carbohydrates

6.4.1 Overview

6.4.2 Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

6.5 Trace Elements

6.5.1 Overview

6.5.2 Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

6.6 Vitamins and Minerals

6.6.1 Overview

6.6.2 Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Parenteral Nutrition Market Analysis - by End User

7.1 Overview

7.2 Hospitals

7.2.1 Overview

7.2.2 Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Clinics

7.3.1 Overview

7.3.2 Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Others

7.4.1 Overview

7.4.2 Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Parenteral Nutrition Market - Country Analysis

8.1 Asia Pacific

8.1.1 Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country

8.1.1.1 China: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.1.1 Overview

8.1.1.1.2 China: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.1.3 China: Parenteral Nutrition Market Breakdown, by Nutrient Type

8.1.1.1.4 China: Parenteral Nutrition Market Breakdown, by End User

8.1.1.2 Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.2.1 Overview

8.1.1.2.2 Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.2.3 Japan: Parenteral Nutrition Market Breakdown, by Nutrient Type

8.1.1.2.4 Japan: Parenteral Nutrition Market Breakdown, by End User

8.1.1.3 India: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.3.1 Overview

8.1.1.3.2 India: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.3.3 India: Parenteral Nutrition Market Breakdown, by Nutrient Type

8.1.1.3.4 India: Parenteral Nutrition Market Breakdown, by End User

8.1.1.4 Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.4.1 Overview

8.1.1.4.2 Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.4.3 Australia: Parenteral Nutrition Market Breakdown, by Nutrient Type

8.1.1.4.4 Australia: Parenteral Nutrition Market Breakdown, by End User

8.1.1.5 South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.5.1 Overview

8.1.1.5.2 South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.5.3 South Korea: Parenteral Nutrition Market Breakdown, by Nutrient Type

8.1.1.5.4 South Korea: Parenteral Nutrition Market Breakdown, by End User

8.1.1.6 Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.6.1 Overview

8.1.1.6.2 Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.6.3 Rest of Asia Pacific: Parenteral Nutrition Market Breakdown, by Nutrient Type

8.1.1.6.4 Rest of Asia Pacific: Parenteral Nutrition Market Breakdown, by End User

9. Industry Landscape

9.1 Overview

9.1.1 Overview

10. Company Profiles

10.1 ICU Medical Inc

10.1.1 Key Facts

10.1.2 Business Description

10.1.3 Products and Services

10.1.4 Financial Overview

10.1.5 SWOT Analysis

10.1.6 Key Developments

10.2 Grifols SA

10.2.1 Key Facts

10.2.2 Business Description

10.2.3 Products and Services

10.2.4 Financial Overview

10.2.5 SWOT Analysis

10.2.6 Key Developments

10.3 Pfizer Inc

10.3.1 Key Facts

10.3.2 Business Description

10.3.3 Products and Services

10.3.4 Financial Overview

10.3.5 SWOT Analysis

10.3.6 Key Developments

10.4 Otsuka Pharmaceuticals Co Ltd

10.4.1 Key Facts

10.4.2 Business Description

10.4.3 Products and Services

10.4.4 Financial Overview

10.4.5 SWOT Analysis

10.4.6 Key Developments

10.5 Baxter International Inc

10.5.1 Key Facts

10.5.2 Business Description

10.5.3 Products and Services

10.5.4 Financial Overview

10.5.5 SWOT Analysis

10.5.6 Key Developments

10.6 B Braun SE

10.6.1 Key Facts

10.6.2 Business Description

10.6.3 Products and Services

10.6.4 Financial Overview

10.6.5 SWOT Analysis

10.6.6 Key Developments

10.7 Fresenius Kabi AG

10.7.1 Key Facts

10.7.2 Business Description

10.7.3 Products and Services

10.7.4 Financial Overview

10.7.5 SWOT Analysis

10.7.6 Key Developments

10.8 Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

10.8.1 Key Facts

10.8.2 Business Description

10.8.3 Products and Services

10.8.4 Financial Overview

10.8.5 SWOT Analysis

10.8.6 Key Developments

10.9 Vifor Pharma Management AG

10.9.1 Key Facts

10.9.2 Business Description

10.9.3 Products and Services

10.9.4 Financial Overview

10.9.5 SWOT Analysis

10.9.6 Key Developments

10.10 Aculife Healthcare Pvt Ltd

10.10.1 Key Facts

10.10.2 Business Description

10.10.3 Products and Services

10.10.4 Financial Overview

10.10.5 SWOT Analysis

10.10.6 Key Developments

11. Appendix

11.1 About The Insight Partners

11.2 Glossary of Terms

List of Tables

Table 1. Parenteral Nutrition Market Segmentation

Table 2. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type

Table 3. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 4. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type

Table 5. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 6. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type

Table 7. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 8. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type

Table 9. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 10. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type

Table 11. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 12. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type

Table 13. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 14. Recent Organic Growth Strategies in the Parenteral Nutrition Market

Table 15. Glossary of Terms, Parenteral Nutrition Market

List of Figures

Figure 1. Parenteral Nutrition Market Segmentation, By Country

Figure 2. Parenteral Nutrition Market: Key Industry Dynamics

Figure 3. Parenteral Nutrition Market: Impact Analysis of Drivers and Restraints

Figure 4. Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030

Figure 5. Parenteral Nutrition Market Share (%) - by Nutrient Type (2022 and 2030)

Figure 6. Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Parenteral Nutrition Market Share (%) - by End User (2022 and 2030)

Figure 12. Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Asia Pacific: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)

Figure 16. Asia Pacific: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 17. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)

Figure 18. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)

Figure 19. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)

Figure 20. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)

Figure 21. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)

Figure 22. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)

1. ICU Medical Inc
2. Grifols SA
3. Pfizer Inc
4. Otsuka Pharmaceuticals Co Ltd
5. Baxter International Inc
6. B Braun SE
7. Fresenius Kabi AG
8. Aculife Healthcare Pvt Ltd 
9. Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
10. Vifor Pharma Management AG

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific parenteral nutrition market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific parenteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific parenteral nutrition market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440